Goldman Sachs Group »

Ani Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 1.5M 1.26

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Ani Pharmaceuticals

Camden Asset Management
Alberta Investment Management Corporation
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
BlackRock
Context Capital Management
Jpmorgan Chase & Co
Leucadia National Corporation
Point72 Asset Management
Polar Securities
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Susquehanna Advisors Group

View all funds holding Ani Pharmaceuticals